Quadrant Capital Group’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,503
Closed -$78.9K 2349
2026
Q1
$78.9K Buy
5,503
+16
+0.3% +$266 ﹤0.01% 1550
2025
Q4
$96.8K Hold
5,487
﹤0.01% 1495
2025
Q3
$86.3K Buy
+5,487
New +$77K ﹤0.01% 1508
2025
Q2
Sell
-534
Closed -$6.23K 2397
2025
Q1
$6.23K Hold
534
﹤0.01% 2315
2024
Q4
$7.31K Hold
534
﹤0.01% 2210
2024
Q3
$8.92K Sell
534
-38
-7% -$555 ﹤0.01% 2176
2024
Q2
$6.79K Hold
572
﹤0.01% 2224
2024
Q1
$6.87K Sell
572
-427
-43% -$6.36K ﹤0.01% 2228
2023
Q4
$16.8K Buy
999
+258
+35% +$3.65K ﹤0.01% 1888
2023
Q3
$11.1K Buy
741
+138
+23% +$2.33K ﹤0.01% 1946
2023
Q2
$11.4K Sell
603
-54
-8% -$858 ﹤0.01% 1949
2023
Q1
$11.8K Sell
657
-239
-27% -$3.99K ﹤0.01% 1954
2022
Q4
$7.46K Buy
896
+778
+659% +$5.81K ﹤0.01% 2083
2022
Q3
$1K Buy
+118
New +$1.96K ﹤0.01% 2560

Other funds holding SHC

Quadrant Capital Group's SHC Position: Q2 2026 in Review

Quadrant Capital Group sold out of Sotera Health (SHC) in Q2 2026, closing a stake of 5,503 shares — an estimated $78.9K sold.

Quadrant Capital Group first reported a position in SHC in Q3 2022 and held it in 14 quarters. The position peaked at $96.8K in Q4 2025. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Quadrant Capital Group reported no remaining Sotera Health position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 5,503 Sotera Health shares in Q2 2026, an estimated $78.9K.
  • Quadrant Capital Group first reported a position in Sotera Health in Q3 2022 and held it in 14 quarters.
  • Quadrant Capital Group's Sotera Health position peaked at $96.8K in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.